Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
Therapeutic drug monitoring (TDM) is uncommon in child and adolescent psychiatry, particularly for selective serotonin reuptake inhibitors (SSRIs)-the first-line pharmacologic treatments for depressive and anxiety disorders. However, TDM in children and adolescents offers the opportunity to leverage...
Saved in:
Main Authors: | Jeffrey R. Strawn (Author), Ethan A. Poweleit (Author), Chakradhara Rao S. Uppugunduri (Author), Laura B. Ramsey (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
by: Ethan A. Poweleit, et al.
Published: (2022) -
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019) -
Talking 'bout digitality
by: Stefan Meier, et al.
Published: (2023) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing
by: Zachary L. Taylor, et al.
Published: (2023)